Jul 15, 2026 07:50AM
Jun 17, 2026 08:48AM
Jun 9, 2026 08:41AM
May 27, 2026 08:11AM
May 7, 2026 03:23PM
May 6, 2026 08:33AM
Mar 31, 2026 08:55AM Ernexa Therapeutics plans first-in-human trials for cancer therapy
Mar 16, 2026 06:07AM
Feb 3, 2026 06:09AM
Jan 27, 2026 08:45AM
Jan 6, 2026 08:15AM
Dec 8, 2025 08:32AM
Oct 29, 2025 08:33AM
Sep 10, 2025 08:30AM Ernexa Therapeutics cuts operating loss by 51% in first half of 2025
Jul 9, 2025 08:30AM
Jun 24, 2025 08:32AM
Jun 11, 2025 04:36PM
Jun 10, 2025 09:30AM
May 8, 2025 08:30AM
Apr 29, 2025 08:33AM
Mar 25, 2025 08:31AM Eterna Therapeutics (ERNA) changes name to Ernexa Therapeutics
Jan 28, 2025 08:31AM
Jan 14, 2025 08:34AM
Dec 3, 2024 08:33AM
Nov 25, 2024 08:30AM
Nov 14, 2024 08:34AM
Nov 5, 2024 04:33PM
Oct 17, 2024 08:01AM Eterna Therapeutics (ERNA) and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases

421,049 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All